Real‐world effectiveness, drug survival and safety of risankizumab over a period of 2 years in 158 patients with moderate‐to‐severe plaque psoriasis.

Authors: Rompoti, Natalia, Stefanaki, Irene, Panagakis, Pantelis, Papoutsaki, Marina, Politou, Maria, Vavouli, Charitomeni, Befon, Angeliki, Kousta, Fiori, Lazou, Eleni, Zaimi, Maria, Koumprentziotis, Ioannis‐Alexios, Chasapi, Vasiliki, Rigopoulos, Dimitrios, Stratigos, Alexander, Nicolaidou, Electra

Source: Journal of the European Academy of Dermatology & Venereology; Jan2025, Vol. 39 Issue 1, pe1-e4, 4p

Subject Terms: FUMARATES, LOGISTIC regression analysis, ADVISORY boards, BIOLOGICALS, RANDOMIZED controlled trials

Real‐world effectiveness and drug survival of guselkumab over a period of 3 years in moderate‐to‐severe plaque psoriasis, including difficult‐to‐treat areas.

Authors: Rompoti, Natalia, Vergou, Theognosia, Stefanaki, Irene, Vavouli, Charitomeni, Koumprentziotis, Ioannis‐Alexios, Panagakis, Pantelis, Papoutsaki, Marina, Politou, Maria, Befon, Angeliki, Kousta, Fiori, Lazou, Eleni, Zaimi, Maria, Chasapi, Vasiliki, Stratigos, Alexander, Nicolaidou, Electra

Source: International Journal of Dermatology; Oct2024, Vol. 63 Issue 10, pe255-e258, 4p

Subject Terms: TUMOR necrosis factors, CYCLOSPORINE, LOGISTIC regression analysis, BODY mass index, DRUG efficacy, PSORIATIC arthritis, BIOTHERAPY

Risankizumab in obese patients with moderate-to-severe plaque psoriasis: a 104-week, real-world, retrospective study.

Authors: Rompoti, Natalia, Koumprentziotis, Ioannis-Alexios, Stefanaki, Irene, Vavouli, Charitomeni, Papoutsaki, Marina, Politou, Maria, Panagakis, Pantelis, Befon, Angeliki, Kousta, Fiori, Lazou, Eleni, Chasapi, Vasiliki, Stratigos, Alexander, Nicolaidou, Electra

Source: Archives of Dermatological Research; Nov2024, Vol. 316 Issue 9, p1-3, 3p

Imiquimod 3.75% for field‐directed therapy of actinic keratosis: results of a prospective case‐series study in Greece

Authors: Befon, Angeliki, Tzanetakou, Vassiliki, Panagiotopoulos, Antonios, Chasapi, Vasiliki, Antoniou, Christina, Stratigos, Alexander J.

Source: International journal of dermatology. 58(9):1040-1044

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100087282896.0x000001&indx=1&recIds=ETOCvdc_100087282896.0x000001

Treatment of postmenopausal frontal fibrosing alopecia with oral dutasteride

Authors: Georgala, Sofia, Katoulis, Alexander C., Befon, Angeliki, Danopoulou, Ifigenia, Georgala, Catherine

Source: In Journal of the American Academy of Dermatology 2009 61(1):157-158

This result is not displayed to guests.
Login for full access.

Bimekizumab Treatment for Scalp Psoriasis: A 52‐Week, Real‐World, Retrospective Study.

Authors: Stefanaki, Irene¹ (AUTHOR), Koumprentziotis, Ioannis‐Alexios¹ (AUTHOR) giannhskmpr@gmail.com, Rompoti, Natalia¹ (AUTHOR), Panagakis, Pantelis² (AUTHOR), Vavouli, Charitomeni¹ (AUTHOR), Papoutsaki, Marina¹ (AUTHOR), Politou, Maria¹ (AUTHOR), Befon, Angeliki² (AUTHOR), Kousta, Fiori² (AUTHOR), Lazou, Eleni² (AUTHOR), Chasapi, Vasiliki² (AUTHOR), Stratigos, Alexander¹ (AUTHOR), Nicolaidou, Electra¹ (AUTHOR)

Source: International Journal of Dermatology. Jan2025, p1. 3p. 1 Illustration.

Subject Terms: *CLINICAL trials, *PSORIATIC arthritis, *SKIN diseases, *TOPICAL drug administration, *OLDER patients